SOLARAPharmaceuticals
Solara Active Pharma Sciences Ltd — Balance Sheet
₹442.70
-3.05%
Solara Active Pharma Sciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net PPE | 1.08K Cr | 1.11K Cr | 1.16K Cr | 1.15K Cr | — |
| Ordinary Shares Number | 4.81 Cr | 3.91 Cr | 3.91 Cr | 3.91 Cr | — |
| Share Issued | 4.81 Cr | 3.91 Cr | 3.91 Cr | 3.91 Cr | — |
| Net Debt | 772.11 Cr | 990.94 Cr | 992.42 Cr | 978.19 Cr | — |
| Total Debt | 796.08 Cr | 1.01K Cr | 1.01K Cr | 1.04K Cr | — |
| Tangible Book Value | 699.54 Cr | 526.26 Cr | 1.08K Cr | 1.09K Cr | — |
| Invested Capital | 1.87K Cr | 1.93K Cr | 2.50K Cr | 2.55K Cr | — |
| Working Capital | -215.38 Cr | -442.10 Cr | 86.41 Cr | 175.86 Cr | — |
| Net Tangible Assets | 699.54 Cr | 526.26 Cr | 1.08K Cr | 1.09K Cr | — |
| Capital Lease Obligations | 20.02 Cr | 12.12 Cr | 11.70 Cr | 12.80 Cr | — |
| Common Stock Equity | 1.09K Cr | 933.91 Cr | 1.50K Cr | 1.52K Cr | — |
| Total Capitalization | 1.21K Cr | 1.04K Cr | 1.74K Cr | 1.81K Cr | — |
| Total Equity Gross Minority Interest | 1.10K Cr | 936.58 Cr | 1.50K Cr | 1.53K Cr | — |
| Minority Interest | 2.67 Cr | 2.67 Cr | 2.24 Cr | 2.31 Cr | — |
| Stockholders Equity | 1.09K Cr | 933.91 Cr | 1.50K Cr | 1.52K Cr | — |
| Other Equity Interest | 1.05K Cr | 1.65 Cr | 1.05 Cr | 1.00 Cr | — |
| Capital Stock | 40.25 Cr | 36.00 Cr | 36.00 Cr | 36.00 Cr | — |
| Common Stock | 40.25 Cr | 36.00 Cr | 36.00 Cr | 36.00 Cr | — |
| Total Liabilities Net Minority Interest | 1.13K Cr | 1.41K Cr | 1.40K Cr | 1.42K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 190.82 Cr | 171.53 Cr | 295.70 Cr | 354.36 Cr | — |
| Other Non Current Liabilities | 48.92 Cr | 43.59 Cr | 38.36 Cr | 50.71 Cr | — |
| Long Term Debt And Capital Lease Obligation | 131.63 Cr | 117.44 Cr | 246.25 Cr | 293.74 Cr | — |
| Long Term Capital Lease Obligation | 17.77 Cr | 11.61 Cr | 11.15 Cr | 10.70 Cr | — |
| Long Term Debt | 113.86 Cr | 105.83 Cr | 235.10 Cr | 283.04 Cr | — |
| Long Term Provisions | 9.85 Cr | 10.08 Cr | 10.67 Cr | 9.49 Cr | — |
| Current Liabilities | 944.11 Cr | 1.24K Cr | 1.10K Cr | 1.06K Cr | — |
| Other Current Liabilities | 10.91 Cr | 16.03 Cr | 5.00 Cr | 5.40 Cr | — |
| Current Debt And Capital Lease Obligation | 664.45 Cr | 894.06 Cr | 766.60 Cr | 743.63 Cr | — |
| Current Capital Lease Obligation | 2.25 Cr | 0.51 Cr | 0.55 Cr | 2.10 Cr | — |
| Current Debt | 662.20 Cr | 893.55 Cr | 766.05 Cr | 741.53 Cr | — |
| Current Provisions | 2.23 Cr | 1.97 Cr | 2.08 Cr | 3.44 Cr | — |
| Payables | 248.63 Cr | 326.53 Cr | 320.01 Cr | 293.81 Cr | — |
| Total Tax Payable | 0.01 Cr | — | 0.01 Cr | 0.33 Cr | 0.14 Cr |
| Accounts Payable | 248.62 Cr | 313.01 Cr | 305.86 Cr | 275.99 Cr | — |
| Total Assets | 2.23K Cr | 2.35K Cr | 2.90K Cr | 2.94K Cr | — |
| Total Non Current Assets | 1.50K Cr | 1.55K Cr | 1.71K Cr | 1.71K Cr | — |
| Other Non Current Assets | 7.12 Cr | 5.28 Cr | 10.07 Cr | 31.55 Cr | — |
| Investmentin Financial Assets | 18.02 Cr | 1.70 Cr | 1.70 Cr | 0.42 Cr | — |
| Available For Sale Securities | 18.02 Cr | 1.70 Cr | 1.70 Cr | 0.42 Cr | — |
| Investment Properties | 2.28 Cr | 2.39 Cr | 23.94 Cr | 24.59 Cr | — |
| Goodwill And Other Intangible Assets | 394.70 Cr | 407.65 Cr | 419.44 Cr | 433.03 Cr | — |
| Other Intangible Assets | 29.80 Cr | 42.56 Cr | 54.35 Cr | 67.94 Cr | — |
| Goodwill | 364.90 Cr | 365.09 Cr | 365.09 Cr | 365.09 Cr | — |
| Gross PPE | 1.08K Cr | 1.63K Cr | 1.61K Cr | 1.51K Cr | — |
| Construction In Progress | 280.05 Cr | 253.62 Cr | 239.66 Cr | 253.80 Cr | — |
| Other Properties | 796.42 Cr | 851.24 Cr | 920.58 Cr | 898.74 Cr | — |
| Current Assets | 728.73 Cr | 800.75 Cr | 1.19K Cr | 1.24K Cr | — |
| Other Current Assets | 67.77 Cr | 63.49 Cr | 0.18 Cr | 65.70 Cr | — |
| Assets Held For Sale Current | 0.00 | 12.68 Cr | 0.00 | — | — |
| Inventory | 317.90 Cr | 359.70 Cr | 558.09 Cr | 575.55 Cr | — |
| Other Receivables | 0.02 Cr | 7.76 Cr | 45.85 Cr | 61.11 Cr | — |
| Accounts Receivable | 326.57 Cr | 348.52 Cr | 536.99 Cr | 489.67 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 16.47 Cr | 8.44 Cr | 8.73 Cr | 46.38 Cr | — |
| Other Short Term Investments | 12.52 Cr | 7.58 Cr | 13.39 Cr | 10.40 Cr | — |
| Cash And Cash Equivalents | 3.95 Cr | 8.44 Cr | 8.73 Cr | 46.38 Cr | — |
| Retained Earnings | — | -317.52 Cr | 249.31 Cr | 273.72 Cr | 338.85 Cr |
| Additional Paid In Capital | — | 1.22K Cr | 1.22K Cr | 1.22K Cr | 1.21K Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 53.67 Cr | 49.03 Cr | 37.07 Cr | 36.56 Cr |
| Current Deferred Taxes Liabilities | — | 0.01 Cr | 0.01 Cr | 0.33 Cr | 0.14 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 1.97 Cr | 2.08 Cr | 3.44 Cr | 1.83 Cr |
| Other Payable | — | 13.36 Cr | 13.99 Cr | 17.65 Cr | 4.07 Cr |
| Dividends Payable | — | 0.16 Cr | 0.16 Cr | 0.17 Cr | 0.15 Cr |
| Non Current Prepaid Assets | — | 27.00 Cr | 27.04 Cr | 38.84 Cr | 19.61 Cr |
| Non Current Deferred Taxes Assets | — | 0.00 | 78.56 Cr | 55.14 Cr | 25.61 Cr |
| Accumulated Depreciation | — | -515.47 Cr | -445.48 Cr | -362.17 Cr | -267.10 Cr |
| Machinery Furniture Equipment | — | 903.24 Cr | 894.82 Cr | 806.40 Cr | 744.03 Cr |
| Buildings And Improvements | — | 331.97 Cr | 333.13 Cr | 316.44 Cr | 297.08 Cr |
| Land And Improvements | — | 138.11 Cr | 138.11 Cr | 138.10 Cr | 137.21 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.16 Cr | 0.16 Cr | 0.87 Cr | 0.85 Cr |
| Prepaid Assets | — | 22.76 Cr | 13.45 Cr | 13.26 Cr | 21.32 Cr |
| Finished Goods | — | 128.54 Cr | 158.39 Cr | 190.71 Cr | 48.43 Cr |
| Work In Process | — | 142.85 Cr | 274.99 Cr | 249.65 Cr | 148.09 Cr |
| Raw Materials | — | 88.31 Cr | 124.71 Cr | 135.19 Cr | 98.45 Cr |
| Taxes Receivable | — | 40.73 Cr | 24.27 Cr | 52.44 Cr | 29.51 Cr |
| Allowance For Doubtful Accounts Receivable | — | -27.19 Cr | -16.20 Cr | -10.54 Cr | -1.72 Cr |
| Gross Accounts Receivable | — | 375.71 Cr | 553.19 Cr | 500.21 Cr | 485.59 Cr |
| Cash Equivalents | — | 5.35 Cr | 0.05 Cr | 42.47 Cr | 194.46 Cr |
| Cash Financial | — | 3.09 Cr | 8.68 Cr | 3.91 Cr | 3.23 Cr |
| Non Current Deferred Revenue | — | — | 0.00 | 23.13 Cr | 28.49 Cr |
| Non Current Deferred Taxes Liabilities | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Solara Active Pharma Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.